Sensitization of estrogen receptor-positive breast cancer cell lines to 4-hydroxytamoxifen by isothiocyanates present in cruciferous plants
Pawlik A, Słomińska-Wojewódzka M, Herman-Antosiewicz A
European journal of nutrition · 39 citas
Etiquetas de revisión
Financiación no declaradaSolo mecanismosDatos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.
Cómo se estudió
- Diseño
- Estudio in vitro o de mecanismos (clasificado por nuestro filtro de IA)
- Estudiado en
- Células o muestras de laboratorio
- Resultado principal
- Solo mecanismos
Quién lo pagó
- Financiación
- Financiación no declarada
Publicación
- Publicado
- 2015-05-26 · Eur J Nutr · vol. 55 · número 3 · págs. 1165–1180
- Editorial
- Springer Science+Business Media
- Citado
- 59 citas · más que el 82% de estudios similares · 1.6× el promedio de su campo
- Referencias
- 65 trabajos
- Acceso
- Acceso abierto (revista híbrida) · CC-BY
- Áreas de investigación
- Genomics, phytochemicals, and oxidative stress · Pharmacological Effects of Natural Compounds · Nitrogen and Sulfur Effects on Brassica
- Palabras clave
- Clonogenic assay, Estrogen receptor, Cancer research, Sulforaphane, Tamoxifen, Breast cancer, Viability assay, Survivin, Pharmacology, Cell growth, Cancer, Cruciferous vegetables, Chemistry, MCF-7, Apoptosis, Cancer cell, Medicine, Internal medicine, Biochemistry, Human breast
- MeSH
- cell line, tumor, humans, brassicaceae, breast neoplasms, sulfides, thiocyanates, tamoxifen, isothiocyanates, sulfoxides, receptors, estrogen, antineoplastic agents, phytogenic, apoptosis, cell proliferation, cell survival, down-regulation, gene expression regulation, neoplastic, drug resistance, neoplasm, bcl-2-associated x protein, inhibitor of apoptosis proteins, mcf-7 cells, perilipin-2, survivin
3 autores
- Anna Pawlik🇵🇱University of Gdańsk
- Monika Słomińska-Wojewódzka🇵🇱University of Gdańsk
- Anna Herman-Antosiewicz🇵🇱 · autor de correspondenciaUniversity of Gdańsk
Resumen
El texto original del estudio, en el idioma en que se publicó.
Purpose
Tamoxifen has been used for the treatment of estrogen receptor (ER)-positive breast cancers and in women who are at an increased risk of breast cancer. Acquired resistance to this drug and its toxicity still pose a clinically significant problem, especially in the prevention setting. Isothiocyanates present in cruciferous plants, such as sulforaphane or erucin, have been shown to reduce growth of breast cancer cells in vivo and in vitro. In this study, we explored their ability to sensitize cancer cells to 4-hydroxytamoxifen.
Methods
We used three ER-positive breast cancer cell lines, T47D, MCF-7 and BT-474, as well as the drug-resistant T47D and MCF-7 derivatives. We examined the effect of 4-hydroxytamoxifen, isothiocyanates and their combinations on cell viability by MTT and clonogenic assays. Impact of treatments on the levels of proteins engaged in apoptosis and autophagy was determined by Western blotting.
Results
Isothiocyanates act in a synergistic way with 4-hydroxytamoxifen, and co-treatment reduces breast cancer cell viability and clonogenic potential more effectively than treatment with any single agent. This is connected with a drop in the Bcl-2/Bax ratio and the level of survivin as well as increased PARP cleavage, and elevation in ADRP, the mitochondrial stress marker. Moreover, isothiocyanates sensitize 4-hydroxytamoxifen-resistant T47D and MCF-7 cells to the drug.
Conclusion
Isothiocyanates enhance response to 4-hydroxytamoxifen, which allows for reduction of the effective drug concentration. Combinatorial strategy may hold promise in development of therapies and chemoprevention strategies against ER-positive breast tumors, even those with acquired resistance to the drug.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.